Clinical Trial Update: SCRI Tissue Testing Registry

View source ↗

Summary

This trial update indicates the SCRI Tissue Testing Registry study has been terminated; it involved patients with melanoma, myelodysplastic syndromes, multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Melanoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Melanoma, Myelodysplastic Syndrome | Status: TERMINATED